5-Bromo-2-ethoxy-3-methylpyridine

Catalog No. :
ACBYUH504
CAS No. :
610279-03-3
Molecular Formula :
C8H10BrNO
Molecular Weight :
216.08

IUPAC Name:5-bromo-2-ethoxy-3-methylpyridine

5-Bromo-2-ethoxy-3-methylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$91.00Login to see priceIn stockInquiry
25g97%$203.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-ethoxy-3-methylpyridine
IUPAC Name5-bromo-2-ethoxy-3-methylpyridine
MDL No.B185547
Molecular FormulaC8H10BrNO
Molecular Weight216.08
SMILESCC1=CC(Br)=CN=C1OCC
InChI KeyKJXFWKLSNMFKSK-UHFFFAOYSA-N
Synonym5-bromo-2-ethoxy-3-methylpyridine | 610279-03-3 | Pyridine, 5-bromo-2-ethoxy-3-methyl- (9CI) | SCHEMBL1404066 | DTXSID50406215 | KJXFWKLSNMFKSK-UHFFFAOYSA-N | MFCD06254608 | AKOS002664318 | BS-28988 | Pyridine,5-bromo-2-ethoxy-3-methyl-(9ci) | CS-0195401 | E89981 | J-516912
CAS No.610279-03-3
PubChem CID4738479

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBYUH504 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACRZOM371 route compound structure diagram
    ACRZOM37129241-60-9 In Stock
  4. Then
  5. ACBYUH504 route product structure diagram
    ACBYUH504610279-03-3 In Stock
Inquiry

2. ACBYUH504 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACRZOM371 route compound structure diagram
    ACRZOM37129241-60-9 In Stock
  4. Then
  5. ACBYUH504 route product structure diagram
    ACBYUH504610279-03-3 In Stock
Inquiry

Comments (0)